Chronic Disease Burden in Ageing Populations — Demand starts with disease prevalence. WHO's 2023 hypertension report counts about 1.3 billion adults with the condition, and roughly four in five aren't adequately treated. In Medicare, more than 60% of enrollees have hypertension, yet only a small fraction receive remote monitoring, according to HHS-OIG. Heart failure, type 2 diabetes and COPD add patients who need frequent readings between visits and carry high readmission costs. Providence's Cadence-run program, which covered more than 2,500 patients across four states, lifted blood pressure control by 43% in relative terms. With ageing populations in the U.S., Europe, Japan and South Korea, the patient base for monitoring keeps widening through 2035.
Remote Patient Monitoring Services Market Size, Share & Forecast
Remote Patient Monitoring Services Market by Component (Devices, Software & Analytics, Services), by Application (Cardiovascular Disease Monitoring, Diabetes Management, Respiratory Disease Monitoring, Weight Management and sleep disorder monitoring), by End User (Hospitals & Providers, Homecare Settings, Payers), by Connectivity (Cellular-Enabled, Bluetooth/Wi-Fi-Enabled, Satellite and Zigbee connectivity), and by Region — Global Industry Perspective, Comprehensive Analysis, and Forecast 2026–2035
Remote Patient Monitoring Services Industry Perspective
The Global Remote Patient Monitoring Services market was valued at USD 12,486.2 Mn in 2025 and is projected to reach USD 49,945.5 Mn by 2035, growing at a CAGR of 14.87% over the 2026–2035 forecast period, according to Vectomat Insights.
North America accounts for 47.0% of 2025 revenue on the back of Medicare's remote physiologic monitoring codes, and within the component mix the services layer is set to overtake devices by 2035, rising from 26.0% to 43.2% of market value.
Remote Patient Monitoring Services Market: Overview
Remote Patient Monitoring Services Market encompasses the connected devices, software platforms and clinical services that let providers track physiologic data between visits and intervene before a patient deteriorates. The report scope covers cellular and Bluetooth blood pressure cuffs, glucose meters and CGMs, ECG patches, implantable-device readers and pulse oximeters; the monitoring, analytics and EHR-integration software that turns readings into alerts; and the onboarding, triage and billing services wrapped around them. Consumer wellness wearables sold without a clinical program fall outside the segmentation framework.
The value chain runs across three tiers. Foundational providers such as Koninklijke Philips, Medtronic, Abbott Laboratories and Omron Healthcare supply the sensors, implantables and hospital-grade monitoring networks. Specialist developers, including Dexcom, iRhythm Technologies, Masimo, Vivalink and Smart Meter, build condition-specific wearables and cellular-connected devices. Application-layer specialists such as Cadence, Biofourmis, Health Recovery Solutions, CoachCare, ChartSpan and Teladoc Health run the platforms and nurse-led programs that health systems actually contract for.
For procurement and investment teams, value is concentrating where clinical labour is sold alongside the data. Managed services and hospital-led programs capture the steepest growth, while device revenue grows more slowly as hardware prices fall. This report breaks the market across 4 segmentation dimensions and 35+ countries in 6 regions, so buyers can see which program models and geographies will carry the forecast.
According to World Health Organization, Global report on hypertension: the race against a silent killer, 2023-09-19, The number of people living with hypertension doubled between 1990 and 2019, from 650 million to 1.3 billion.

Key Insights
- The market grows from USD 12,486.2 Mn in 2025 to USD 49,945.5 Mn in 2035, a 14.87% CAGR across the 2026–2035 forecast horizon.
- Devices lead the component mix with 44.0% of 2025 revenue (USD 5,493.9 Mn), anchored by connected blood pressure cuffs, glucose meters, CGMs and implantable cardiac monitor readers.
- Services are the fastest-growing component at a 20.86% CAGR and reach USD 21,581.6 Mn by 2035, overtaking devices as the largest component.
- Cardiovascular disease monitoring is the leading application at 31.7% (USD 3,956.0 Mn), because hypertension and heart failure dominate Medicare RPM enrollment.
- Hospitals & Providers are the dominant end user at 45.8% and also the fastest-growing, at 19.6% a year, as health systems fold RPM into primary care workflows.
- North America holds 47.0% of 2025 revenue (USD 5,868.5 Mn); the U.S. alone is worth USD 4,988.2 Mn and grows at 13.7% to USD 18,011.4 Mn by 2035.
- Asia Pacific is the fastest-growing region, with South Korea expanding at 17.1% and Japan at 15.2% a year after telemedicine reforms.
- Consolidation is accelerating: CoachCare, Health Recovery Solutions and ChartSpan each bought a monitoring or data platform between March 2025 and June 2026.
- Diabetes management grows at 20.04% a year and becomes the largest application by 2035 at USD 20,412.9 Mn as CGM use extends to non-insulin type 2 patients.

Remote Patient Monitoring Services Market: Report Scope
| Report Name | Remote Patient Monitoring Services Market by Component (Devices, Software & Analytics, Services), by Application (Cardiovascular Disease Monitoring, Diabetes Management, Respiratory Disease Monitoring, Weight Management and sleep disorder monitoring), by End User (Hospitals & Providers, Homecare Settings, Payers), by Connectivity (Cellular-Enabled, Bluetooth/Wi-Fi-Enabled, Satellite and Zigbee connectivity), and by Region — Global Industry Perspective, Comprehensive Analysis, and Forecast 2026–2035 |
|---|---|
| Market Size in 2025 | USD 12,486.2 Mn (2025) |
| Market Forecast in 2035 | USD 49,945.5 Mn (2035) |
| Growth Rate (CAGR) | 14.87% |
| Historical Data Period | 2023–2025 |
| Base Year | 2025 |
| Forecast Period | 2026–2035 |
| Number of Pages | 300+ |
| Tables & Figures | 98 tables & 72 figures |
| Report Code | VMI-1-6-71851 |
| Report Format | |
| Delivery Format | PDF via email delivery and online download portal |
| Published Date | November 2026 |
| Research Methodology | Primary interviews + secondary research + verified market sizing (top-down and bottom-up triangulation) |
| Key Companies Covered | Koninklijke Philips, Medtronic, Abbott Laboratories, Omron Healthcare, Dexcom, iRhythm Technologies, Masimo, Vivalink, Smart Meter, Teladoc Health, Biofourmis, Cadence, Health Recovery Solutions, CoachCare, ChartSpan |
| Segments Covered | Component, Application, End User, Connectivity |
| Regions Covered | North America, Europe, Asia Pacific, Latin America, The Middle East, Africa |
| Customization Scope | Up to 10% free customization: additional country breakdowns, company profiles or segment cuts (for example, RPM services by payer type or by care-program model) |
Why This Remote Patient Monitoring Services Market Report Matters
Decision-makers comparing market intelligence reports on Remote Patient Monitoring Services will find the VMI report differentiated on the following dimensions.
| Dimension | VMI Report | Industry Average |
|---|---|---|
| Report Pages | 300+ | ~120 pages |
| Forecast Horizon | 10 years | 7 years |
| Segmentation Dims | 4 dims | 4-5 dimensions |
| Historical Data | 3 years | 4-5 years |
| Country Coverage | 35+ countries | 15-18 countries |
| Companies Profiled | 15 companies | 10-12 companies |
| DROC Framework | Full (4 elem) | Drivers only |
For custom scope — additional segments, specific geographies, or extended forecast periods — contact sales@vectomatinsights.com
Why Is the Remote Patient Monitoring Services Market Growing?
Expanding Reimbursement for RPM — Reimbursement turned RPM into a business. Medicare payments for remote monitoring climbed from USD 15 Mn in 2019 to USD 536 Mn in 2024, with nearly 1 million enrollees that year, according to HHS-OIG. The CY2026 Physician Fee Schedule goes further: device-supply billing now starts at 2 days of data in a 30-day period rather than 16, and a shorter management tier pays for 10 minutes of clinical time. That change brings intermittent users, such as post-discharge heart failure patients, into billable programs. Germany's 2022 telemonitoring codes for heart failure show the same mechanism at work in Europe. Medicare's payment line rose 31% in 2024 alone.
Outsourced Clinical Monitoring Services — Clinical labour, not hardware, is the bottleneck. Health systems can't add enough nurses to watch thousands of daily readings, so they're buying fully managed programs instead. Providence reports that only 0.6% of remote encounters handled by Cadence's team escalate to Providence clinicians, and Corewell Health embedded the same model into primary care in 2026. Service providers are scaling through acquisition to meet that demand: CoachCare bought VitalTech in March 2025 and Health Recovery Solutions bought Rimidi in March 2026. Services are therefore the fastest-growing component at 20.86% a year. Cadence's USD 100 Mn Series C in June 2026 is the clearest bet on this model.
Longer-Wear and Connected Sensors — Better sensors keep patients enrolled. Dexcom won FDA clearance for the 15-day G7 in April 2025, and Abbott gained approval in February 2026 for a CardioMEMS HERO reader with built-in Wi-Fi and cellular links and a lighter design. Smart Meter's cellular devices transmit without a smartphone, which matters for older patients. Each upgrade lowers the effort a patient must spend to send a reading, and adherence is what decides whether a month of monitoring can be billed. In structural terms, device innovation in this market is less about new measurements than about turning a daily chore into a passive data stream.
The promise was this continuous stream of objective, reliable data would replace the unreliable, intermittent information we had been forced to make decisions from.
Cadence's services are accessible 24/7 and help triage emergent, urgent and non-urgent issues, which reduces the burden on Providence clinicians.
What's Limiting the Remote Patient Monitoring Services Market?
Billing Oversight and Compliance Risk — Compliance exposure is the sharpest brake on growth. HHS-OIG's September 2024 report found that 43% of Medicare enrollees who received RPM in 2022 didn't get all three components: setup, device supply and treatment management. A 2025 follow-up report said some RPM billing poses a risk to Medicare, and OIG and CMS have warned about vendors enrolling patients who don't need monitoring. Programs now need audit-ready documentation for every billed month. Expect tighter payer review to slow enrollment for smaller practices through 2027.
Patient Adherence and Data Gaps — Adherence decides program economics. A patient who stops taking readings drops out of billing, and drop-off is highest in the first 90 days, when setup problems and low digital literacy bite. Older patients without smartphones or home Wi-Fi struggle with Bluetooth pairing, which is why cellular devices still hold 50.0% of 2025 connectivity revenue. Language barriers and rural coverage gaps widen the problem. Even well-run programs, such as Corewell Health's, report engagement in the 80% range rather than near-universal use.
Clinical Staffing and Alert Burden — Monitoring creates work before it saves it. Each enrolled patient sends readings that someone must review, document and act on, and most health systems lack spare nursing capacity to do it in-house. Cadence's founder describes the clinical labour constraint as the core problem the company was built to solve. Programs that skip triage protocols end up flooding physicians with alerts and then shrinking enrollment to cope. The cost line is real: staff time is the largest expense in a managed RPM contract.
Additional oversight of remote patient monitoring in Medicare is needed to ensure it is used and billed appropriately.
Emerging Opportunities in the Remote Patient Monitoring Services Market
CGM Monitoring for Non-Insulin Type 2 Diabetes — Diabetes management grows at 20.04% a year, the fastest of any application, and becomes the largest by 2035 at USD 20,412.9 Mn. CGMs are moving beyond insulin users: Dexcom launched Stelo and, in May 2026, Dexcom Flex for type 2 patients in Germany. Abbott's March 2026 study on Libre in basal-insulin type 2 patients adds evidence payers ask for. Programs that pair CGM data with nurse coaching can bill monitoring and care management together. This shift should keep diabetes volume growing faster than any other condition through the forecast horizon.
Hospital-at-Home and Virtual Wards — Acute care at home needs continuous monitoring, and buyers are signing long contracts for it. Philips agreed in May 2026 to supply hospital-at-home technology for up to 15,000 patients a year in Region Stockholm, and Biofourmis was selected by AdventHealth in January 2025 for a new Acute Care at Home program. NHS England's virtual wards already treat more than 100,000 patients a year. These programs pay more per patient than chronic RPM, because monitoring is continuous. The Stockholm contract alone sets a 15,000-patient annual benchmark.
Telemedicine Reform in Asia Pacific — South Korea's December 2025 Medical Service Act amendment puts telemedicine on a permanent legal footing after years of pilots. That legal base lets hospitals and platform operators design reimbursed home-monitoring programs for an ageing population, and the country's market grows at 17.1% a year. Japan, growing at 15.2%, already reimburses remote monitoring for implanted cardiac devices and home dialysis. Vendors with Korean and Japanese regulatory approvals are best placed, with Omron's AI-enabled home blood pressure monitors a ready example.
Value-Based Care Contracts — Monitoring that cuts total cost of care fits risk-based contracts better than fee-for-service. Providence reports its Cadence program reduced total cost of care by USD 1,302 per Medicare patient per year. Payers already hold 18.2% of 2025 spend and grow at 12.72%, buying monitoring through care-management vendors. Teladoc's February 2025 deal for Catapult Health adds at-home testing to that offer. Structurally, this moves RPM from a billing code into a cost-avoidance service that Medicare Advantage plans and accountable care organizations can price.
What's Holding Back the Remote Patient Monitoring Services Market?
Cybersecurity of Home-Connected Devices — Every device in a patient's home sits outside hospital security controls. Medtronic updated its CareLink network vulnerability bulletin in January 2026, a reminder that remote cardiac networks are attack surfaces. Health-system security teams now ask for device patching and data-encryption evidence before signing. Security reviews are adding weeks to procurement cycles.
Interoperability Across Mixed Device Fleets — Programs run cuffs, scales, CGMs and implants from different makers, and each sends data in its own format. Clinicians won't work in a separate portal, so platforms must integrate with Epic or Oracle Health. ChartSpan's June 2026 purchase of Validic, a device-data integration company, shows service providers buying the integration layer rather than building it.
Clinician Workflow and Alert Fatigue — Too many low-value alerts erode clinician trust in monitoring. Programs without triage rules push readings straight to physicians, who then disengage. Providence addressed this by setting clinical guidelines in advance and letting Cadence's team triage, with only 0.6% of encounters escalated to its clinicians.
We built Cadence to solve the clinical labor constraint at the heart of the chronic disease crisis.

Where AI Fits Into the Remote Patient Monitoring Services Market
AI is moving into the alert layer, where it decides which readings a nurse needs to see. Masimo won FDA 510(k) clearance in June 2026 for AI-enabled detection of opioid-induced respiratory depression on its Radius VSM wearable, and Omron's home blood pressure monitors carry an AI-powered AFib detection feature authorized in November 2024. Medtronic runs AccuRhythm AI algorithms on its LINQ II insertable cardiac monitors to cut false arrhythmia alerts before they reach clinicians.
For buyers, the payoff is labour: fewer false alerts mean each nurse can cover more patients, which is the binding cost in a managed program. Cadence said in June 2026 it will use new funding to expand AI agents that monitor vitals and flag risks. Over the forecast horizon, expect contracts to price AI triage as part of the service fee rather than as separate software.
Remote Patient Monitoring Services Market: Segmentation
The Global Remote Patient Monitoring Services market is segmented by Component, Application, End User, Connectivity.
By Component
Medicare's 2026 codes now pay for as few as 2 days of readings a month, which widens the pool of billable patients for every program model. Devices remain the largest component at 44.0% of 2025 revenue, or USD 5,493.9 Mn, because each enrollment starts with a cuff, meter, CGM or implant reader that's billed monthly. Services are the fastest mover: they grow at 20.86% a year and reach USD 21,581.6 Mn by 2035, overtaking devices as health systems outsource triage to nurse-led teams. Software & Analytics grows slowest, at 7.47%, as platforms get bundled into those service contracts. Cadence's USD 100 Mn Series C in June 2026 shows where investors think the margin sits.
Year-on-Year Remote Patient Monitoring Services Market Revenue By Component (2023–2025, USD Million)
| Sub-Segment | 2023 (USD Mn) | 2024 (USD Mn) | 2025 (USD Mn) |
|---|---|---|---|
| Devices | 3,829.0 | 4,658.4 | 5,493.9 |
| Software & Analytics | 3,480.6 | 3,718.0 | 3,745.9 |
| Services | 2,348.9 | 2,656.4 | 3,246.4 |

By Application
About 1.3 billion adults live with hypertension, according to WHO, and that single condition shapes the application mix. Cardiovascular Disease Monitoring leads with 31.7% of 2025 revenue, or USD 3,956.0 Mn, since blood pressure and heart failure programs carry the clearest readmission economics. Diabetes Management is the fastest-growing application at 20.04% a year and becomes the largest by 2035 at USD 20,412.9 Mn, as CGMs move into non-insulin type 2 care. Respiratory Disease Monitoring holds 18.0% and grows at 11.26%. Weight Management and sleep disorder monitoring, at 24.0%, slows to 6.8% as obesity programs shift toward drug-led care. Dexcom's May 2026 launch of Dexcom Flex for type 2 patients in Germany points to where diabetes volume will come from.
Year-on-Year Remote Patient Monitoring Services Market Revenue By Application (2023–2025, USD Million)
| Sub-Segment | 2023 (USD Mn) | 2024 (USD Mn) | 2025 (USD Mn) |
|---|---|---|---|
| Cardiovascular Disease Monitoring | 2,979.5 | 3,430.9 | 3,956.0 |
| Diabetes Management | 2,830.6 | 3,112.1 | 3,286.0 |
| Respiratory Disease Monitoring | 1,860.4 | 2,087.3 | 2,247.5 |
| Weight Management and sleep disorder monitoring | 1,988.0 | 2,402.5 | 2,996.7 |
By End User
Provider-led programs now set the pace, because the clinician who orders monitoring is also the one who bills for acting on it. Hospitals & Providers are both dominant and fastest-growing: they hold 45.8% of 2025 revenue, or USD 5,716.2 Mn, and grow at 19.6% a year to USD 34,239.8 Mn by 2035. Homecare Settings take 36.0% but grow at only 6.16%, as agency-run programs lose ground to health-system contracts. Payers hold 18.2% and grow at 12.72%, buying monitoring through care-management vendors. Corewell Health is a clear example: it embedded Cadence's program directly into primary care and reported more than 80% patient engagement in 2026.
Year-on-Year Remote Patient Monitoring Services Market Revenue By End User (2023–2025, USD Million)
| Sub-Segment | 2023 (USD Mn) | 2024 (USD Mn) | 2025 (USD Mn) |
|---|---|---|---|
| Hospitals & Providers | 4,486.6 | 4,946.7 | 5,716.2 |
| Homecare Settings | 3,469.2 | 4,014.0 | 4,495.0 |
| Payers | 1,702.7 | 2,072.1 | 2,275.0 |

By Connectivity
Coverage gaps decide which radio goes in the box: an RPM reading that never arrives can't be billed. Cellular-Enabled devices dominate with 50.0% of 2025 revenue, or USD 6,243.1 Mn, because they pair out of the box with no smartphone or router, though growth slows to 9.44% a year. Satellite and Zigbee connectivity is the fastest-growing segment at 22.83%, rising to USD 15,610.7 Mn by 2035 as non-terrestrial network modules reach wearables and home hubs. Bluetooth/Wi-Fi-Enabled devices hold 34.0% and grow at 16.13% as smartphone-first CGMs scale. Smart Meter's January 2026 launch of the iGlucose Touch cellular meter shows vendors still betting on plug-and-play cellular for older patients.
Year-on-Year Remote Patient Monitoring Services Market Revenue By Connectivity (2023–2025, USD Million)
| Sub-Segment | 2023 (USD Mn) | 2024 (USD Mn) | 2025 (USD Mn) |
|---|---|---|---|
| Cellular-Enabled | 5,617.3 | 6,267.7 | 6,243.1 |
| Bluetooth/Wi-Fi-Enabled | 2,837.9 | 3,274.7 | 4,245.3 |
| Satellite and Zigbee connectivity | 1,203.3 | 1,490.4 | 1,997.8 |

Remote Patient Monitoring Services Market: Production & Volume Analysis, 2025
Vectomat Insights counts about 9.4 million active patient enrollments worldwide in 2025, with an enrollment defined as one patient on a billed monitoring program during the year. That implies average revenue of roughly USD 1,328 per enrolled patient. The volume-value split is telling: device-led programs hold 46.5% of enrollments against 44.0% of value, and software-licensed programs take 35.0% of enrollments but 30.0% of value. Fully managed services cover only 18.5% of patients yet earn 26.0% of revenue, about USD 1,870 per patient, because clinical staff time is priced into each contract.
| Metric | 2025 Volume (active patient enrollments) | Share of Units |
|---|---|---|
| Total active patient enrollments (2025) | 9,400,000 | 100.0% |
| Devices | 4,371,000 | 46.5% |
| Software & Analytics | 3,290,000 | 35.0% |
| Services | 1,739,000 | 18.5% |
Reference point: Koninklijke Philips — Contracted with Region Stockholm to supply hospital-at-home monitoring technology for up to 15,000 patients a year (May 2026).
Remote Patient Monitoring Services Market: Competitive Landscape
Market structure is fragmented at the service layer and concentrated at the sensor layer. A handful of device majors control implantable and CGM data streams, while dozens of service providers compete for health-system contracts, and that second tier is consolidating. Hospitals now prefer one vendor that ships the device, runs the platform and staffs the monitoring desk, which favours companies able to bundle all three. Price competition is sharpest in cuff-and-scale hypertension programs; differentiation holds up best in implant-based heart failure and CGM-led diabetes monitoring. Key players include Koninklijke Philips, Medtronic, Abbott Laboratories, Omron Healthcare, Dexcom, iRhythm Technologies, Masimo, Vivalink, Smart Meter, Teladoc Health, Biofourmis, Cadence, Health Recovery Solutions, CoachCare and ChartSpan, among others.
| Company | HQ Country | Primary Focus | Key Strategy | Notable Recent Action |
|---|---|---|---|---|
| Koninklijke Philips | Netherlands | Enterprise patient monitoring, telemetry and hospital-at-home platforms | Open monitoring ecosystem with partners such as Masimo, plus AI-enabled monitoring for workforce-constrained hospitals | Won a Region Stockholm contract in May 2026 to supply hospital-at-home monitoring for up to 15,000 patients a year |
| Medtronic | Ireland | CareLink remote network for implantable cardiac devices, LINQ II monitors with AccuRhythm AI, and MiniMed diabetes systems | AI on implantables and CGM interoperability through its sensor partnership with Abbott | Received FDA clearance in January 2026 for the MiniMed Go smart MDI system featuring the Instinct sensor made by Abbott |
| Abbott Laboratories | United States | Implantable heart failure pressure monitoring (CardioMEMS) and FreeStyle Libre continuous glucose monitoring | Sensor-led chronic disease monitoring sold at consumer scale, with partner integrations for insulin delivery | Won FDA approval in February 2026 for the next-generation CardioMEMS HERO reader with built-in Wi-Fi and cellular connectivity |
| Omron Healthcare | Japan | Connected home blood pressure monitors and the Luscii remote monitoring platform | 'Going for Zero' strategy to cut heart attacks and strokes through home blood pressure data and AI features | Received FDA De Novo authorization in November 2024 for blood pressure monitors with AI-powered AFib detection |
| Dexcom | United States | Real-time continuous glucose monitoring (G7, Stelo, G8 pipeline) | Longer sensor wear, expansion into non-insulin type 2 diabetes, and international growth | Launched Dexcom Flex for people with type 2 diabetes in Germany in May 2026 |
| iRhythm Technologies | United States | Zio long-term continuous ECG monitoring and cardiac arrhythmia detection | Add mobile cardiac telemetry, expand into primary care and grow outside the U.S. | Reported third-quarter 2026 results in November 2026 under its new parent name, iRhythm Holdings |
| Masimo | United States | Wearable hospital-to-home monitoring (Radius VSM) and SET pulse oximetry | AI-enabled alarms plus an OEM partnership with Philips | Received FDA 510(k) clearance in June 2026 for AI-enabled opioid-induced respiratory depression detection on Radius VSM |
| Vivalink | United States | Wearable biosensors and data platform for ambulatory cardiac monitoring and hospital-at-home | Supply wearable sensors and data infrastructure to monitoring-service partners | Partnered with Artella Solutions in December 2025 on an end-to-end ambulatory cardiac monitoring service |
| Smart Meter | United States | Cellular-connected glucose meters, blood pressure cuffs, scales and thermometers for RPM programs | Out-of-the-box cellular devices that need no smartphone or home Wi-Fi | Launched the iGlucose Touch touchscreen cellular-connected blood glucose meter in January 2026 |
| Teladoc Health | United States | Virtual care and chronic condition management, including the Livongo programs | Integrated care with home testing and international expansion through acquisitions | Agreed in February 2025 to acquire Catapult Health for USD 65 Mn to add at-home testing to chronic care |
| Biofourmis | United States | AI-driven in-home care, remote monitoring and acute care at home | End-to-end in-home care platform sold to health systems after its merger with CopilotIQ | Selected by AdventHealth in January 2025 to support a new Acute Care at Home program |
| Cadence | United States | Nurse-practitioner-led remote care programs for hypertension, heart failure and diabetes, run for health systems | Fully managed clinical service paid through RPM codes, with AI agents to extend clinical capacity | Raised a USD 100 Mn Series C led by Spark Capital in June 2026 |
| Health Recovery Solutions | United States | Remote monitoring and virtual care platform for health systems and home health agencies | Consolidation into condition-specific chronic care programs | Acquired Rimidi, a diabetes and cardiometabolic care platform, in March 2026 |
| CoachCare | United States | RPM and chronic care management software and services for physician practices | Roll-up of complementary monitoring platforms | Acquired VitalTech, an enterprise virtual care software company, in March 2025 |
| ChartSpan | United States | Chronic care management and RPM services for medical practices | Add device-data infrastructure through acquisition | Acquired Validic, a personal health data and connected-device integration platform, in June 2026 |
Three strategic themes stand out. First, roll-ups: CoachCare, Health Recovery Solutions and ChartSpan each bought a monitoring or data company between March 2025 and June 2026 to widen clinical coverage. Second, sensor upgrades that cut patient burden, from Dexcom's 15-day G7 to Abbott's connected HERO reader. Third, AI at the alert layer, where Masimo, Omron and Cadence all aim to triage readings before a clinician sees them.

Remote Patient Monitoring Services Market: From Raw Material to Delivery
Device manufacturing and connectivity — Sensor makers build blood pressure cuffs, glucose meters, CGMs, ECG patches and implant readers, then add cellular, Bluetooth or Wi-Fi modules and carrier contracts. Margins depend on sensor accuracy, wear time and the cost of keeping a device connected for months. FDA clearance and MDR certification set the pace of new launches, and cellular data plans are a recurring cost most programs pass through in the monthly device fee. Key Players: Key Players: Abbott Laboratories, Dexcom, Omron Healthcare, Smart Meter.
Platform and data integration — Software platforms collect readings from mixed device fleets, apply alert rules and push results into the EHR. Integration is the hard part: health systems run Epic or Oracle Health and won't accept a separate login for clinicians. This is why ChartSpan bought Validic in June 2026. Platform vendors increasingly sell to service companies rather than directly to hospitals. Data security now shapes procurement too, after Medtronic updated its CareLink network vulnerability bulletin in January 2026. Key Players: Key Players: Koninklijke Philips, Health Recovery Solutions, ChartSpan (Validic), Vivalink.
Clinical service delivery and billing — Nurse and care-coordinator teams onboard patients, review alerts, call patients and escalate to the ordering clinician, then document the minutes needed to bill treatment-management codes. Labour is the largest cost line. Providence reports only 0.6% of remote encounters handled by Cadence escalate to its own clinicians, which is the economic case for outsourcing this stage. Service contracts are usually priced per enrolled patient per month, so enrollment volume and staff ratios decide profitability. Key Players: Key Players: Cadence, CoachCare, Biofourmis, Teladoc Health.
Remote Patient Monitoring Services Market: Regional Analysis
North America leads with 47.0% of 2025 revenue because Medicare pays a monthly fee for each monitored patient, while Asia Pacific is the fastest-growing region as South Korea and Japan move remote care into law and fee schedules. The split reflects reimbursement maturity more than device access.
North America Remote Patient Monitoring Services Market
A reimbursement-led market built on Medicare's monitoring codes explains why North America holds 47.0% of 2025 revenue, worth USD 5,868.5 Mn. The U.S. accounts for USD 4,988.2 Mn of that and grows at 13.7% a year to USD 18,011.4 Mn by 2035. Medicare enrollment in RPM reached nearly 1 million people in 2024, and payments rose 31% in a single year to USD 536 Mn. Service providers are consolidating fast: CoachCare, Health Recovery Solutions and ChartSpan each closed a platform deal between March 2025 and June 2026. Canada and Mexico add smaller, province- and insurer-funded programs. The main risk is compliance, after HHS-OIG found 43% of 2022 Medicare RPM patients missed at least one service component. Expect the 2026 short-duration codes to pull more low-acuity patients into monitoring through the rest of the decade.
United States Remote Patient Monitoring Services Market Snapshot
| Metric | Value |
|---|---|
| Market Size (2025) | USD 4,988.2 Mn |
| Forecast Value (2035) | USD 18,011.4 Mn |
| CAGR (2026–2035) | 13.7% |

Europe Remote Patient Monitoring Services Market
Europe's growth runs through national health systems rather than a single payer code, and that shapes its 22.0% share, or USD 2,747.0 Mn, in 2025. Germany leads at USD 714.2 Mn and grows at 13.3% a year, helped by the statutory telemonitoring benefit for heart failure patients that came with new EBM billing codes in 2022. The U.K. has scaled NHS England's virtual wards to about 10,000 beds that treat more than 100,000 patients a year. Philips' May 2026 contract to support up to 15,000 hospital-at-home patients a year in Region Stockholm shows Nordic buyers moving the same way. Fragmented reimbursement rules and MDR certification costs still keep most vendors country-by-country. Germany is on track for USD 2,489.5 Mn by 2035.
Germany Remote Patient Monitoring Services Market Snapshot
| Metric | Value |
|---|---|
| Market Size (2025) | USD 714.2 Mn |
| Forecast Value (2035) | USD 2,489.5 Mn |
| CAGR (2026–2035) | 13.3% |

Asia Pacific Remote Patient Monitoring Services Market
Legal reform is the trigger in Asia Pacific, the fastest-growing region, which holds 20.0% of 2025 revenue, or USD 2,497.2 Mn. South Korea's National Assembly passed a Medical Service Act amendment in December 2025 that puts telemedicine on a permanent footing after 15 years of pilots, and the country's RPM services market grows at 17.1% a year from USD 424.5 Mn in 2025. Japan is larger today at USD 649.3 Mn, growing at 15.2%, with fee-schedule support for remote monitoring of home dialysis and implanted cardiac devices. India's eSanjeevani passed 500 million teleconsultations in October 2026, building the patient base for monitoring at scale. Reimbursement outside Japan and Korea is still patchy. Philips set out an AI-enabled patient monitoring strategy for Asian hospitals facing workforce shortages in May 2026.
South Korea Remote Patient Monitoring Services Market Snapshot
| Metric | Value |
|---|---|
| Market Size (2025) | USD 424.5 Mn |
| Forecast Value (2035) | USD 2,058.0 Mn |
| CAGR (2026–2035) | 17.1% |

Latin America Remote Patient Monitoring Services Market
Latin America holds 6.0% of 2025 revenue, about USD 749.2 Mn, and Brazil carries most of it. Brazil's Lei 14.510 of December 2022 gave telehealth a permanent legal basis across the public SUS network and private operators, so hospital groups in São Paulo and Rio can now build home-monitoring programs on settled rules. Private insurers buy most of the region's monitoring today, usually for heart failure and diabetes members after discharge. Low insurance penetration outside cities and patchy rural cellular coverage keep volumes modest. What the region has, then, is a legally permitted but payer-limited market, where growth depends on operators proving lower readmissions rather than on a fee code.
The Middle East Remote Patient Monitoring Services Market
The Middle East accounts for 3.0% of 2025 revenue, or USD 374.6 Mn, and demand is concentrated in a handful of government programs. Saudi Arabia's SEHA Virtual Hospital, launched in 2022 with a live network of 130 connected hospitals, gives the Ministry of Health a central hub for remote specialist and monitoring services. The UAE adds insurer-funded chronic care programs, while Israel contributes device and analytics developers that sell into larger markets. Diabetes prevalence across the GCC keeps glucose monitoring in front of buyers. Tender-driven purchasing and small private-payer pools remain the constraint. GCC procurement plans point to steady expansion of home monitoring within national virtual-care networks through 2035.
Africa Remote Patient Monitoring Services Market
Africa is the smallest region at 2.0% of 2025 revenue, about USD 249.7 Mn, with South Africa and Egypt the two largest country markets. South Africa leads, where the Health Professions Council's telehealth guidelines, revised in 2021, allow remote consultations and follow-up, and private medical schemes fund a limited number of chronic-care monitoring programs. Device costs, thin reimbursement and uneven connectivity outside metropolitan areas keep adoption low, and most programs still rely on donor or employer funding. Even so, the region's base-year value implies fewer than 200,000 monitored patients at average global revenue per enrollment, a 2.0% share that leaves ample room for growth.


Full Country Coverage
| Region | Countries Covered |
|---|---|
| North America | The U.S., Canada, Mexico |
| Europe | Germany, France, U.K., Italy, Spain, Russia, BENELUX, Sweden, Denmark, Poland, Austria, Rest of Europe |
| Asia Pacific | China, Japan, India, South Korea, Australia, Thailand, Indonesia, Vietnam, Malaysia, Philippines, Taiwan, Rest of Asia Pacific |
| Latin America | Brazil, Argentina, Colombia, Chile, Peru, Rest of Latin America |
| The Middle East | GCC (Saudi Arabia, UAE, Qatar, Kuwait, Bahrain, Oman), Israel, Turkey, Iran, Rest of Middle East |
| Africa | South Africa, Egypt, Nigeria, Algeria, Morocco, Rest of Africa |
Note: Country-level market sizing, historical data, and forecasts available for all geographies listed. Custom regional add-ons available — contact sales@vectomatinsights.com
How Governments Are Supporting the Remote Patient Monitoring Services Market
Reimbursement and funding initiative — The U.S. Centers for Medicare & Medicaid Services finalized 2026 Physician Fee Schedule codes that pay for 2–15 days of monitoring data in a 30-day period and add a shorter management tier, effective 1 January 2026, widening billable enrollment. (CMS Physician Fee Schedule remote physiologic monitoring codes (CY2026))
Statutory telemonitoring benefit — Germany made telemonitoring for patients with advanced heart failure a statutory insurance benefit, with new EBM billing codes introduced in 2022 for both the treating physician and the telemedicine centre. (Telemonitoring bei Herzinsuffizienz (EBM, 2022))
Hospital-at-home and virtual ward program — NHS England reached its target of about 10,000 virtual ward beds and treats more than 100,000 patients a year at home with remote monitoring, creating steady public demand for devices and monitoring services. (NHS England virtual wards)
Telemedicine legalization and digital public infrastructure — South Korea's National Assembly passed a Medical Service Act amendment in December 2025 institutionalizing telemedicine, while India's eSanjeevani passed 500 million teleconsultations in October 2026 under the Ayushman Bharat Digital Mission. (Medical Service Act amendment (South Korea, 2025); eSanjeevani (India))
What's New in the Remote Patient Monitoring Services Market?
Activity since early 2025 has been dominated by service-provider acquisitions and reimbursement changes, with device makers contributing connectivity upgrades rather than new categories.
| Date | Company | Type | Description | Market Impact |
|---|---|---|---|---|
| Mar 2025 | CoachCare | M&A | Acquired VitalTech, a Dallas-based enterprise virtual care software company, adding platform capacity to its RPM and chronic care management services. [source] | Accelerates service-layer consolidation and broadens CoachCare's health-system reach. |
| Nov 2025 | Centers for Medicare & Medicaid Services | Regulatory | Finalized CY2026 Physician Fee Schedule codes that pay for 2–15 days of remote monitoring data per 30-day period and a shorter management tier, effective 1 January 2026. [source] | Expands the pool of billable patients and favours short-duration post-discharge programs. |
| Feb 2026 | Abbott Laboratories | Regulatory | Received FDA approval for the next-generation CardioMEMS HERO pulmonary artery pressure reader with built-in Wi-Fi and cellular connectivity for remote heart failure monitoring. [source] | Lowers patient burden in implant-based heart failure monitoring and supports higher daily transmission rates. |
| Mar 2026 | Health Recovery Solutions | M&A | Acquired Rimidi, a diabetes and cardiometabolic care management platform, to expand its remote care programs. [source] | Adds condition-specific depth to a general RPM platform, a template for further roll-ups. |
| Jun 2026 | ChartSpan | M&A | Acquired Validic, a connected-device and personal health data integration platform, to strengthen its remote patient monitoring capabilities. [source] | Moves device-data infrastructure inside a service provider, raising the bar for point-solution vendors. |
| Jun 2026 | Cadence | Investment | Raised a USD 100 Mn Series C led by Spark Capital to expand its remote care services, AI agents and value-based care models across health systems. [source] | Signals investor confidence in fully managed, staff-inclusive RPM programs. |
Research Methodology
Overall approach
Vectomat Insights sized the remote patient monitoring services market bottom-up from enrolled patients and annual revenue per enrollment by component, then cross-checked the result top-down against public device-maker and service-provider revenue, Medicare RPM payment data and national telemonitoring program volumes. The 2023–2025 history and 2026–2035 forecast are modeled by component, application, end user, connectivity and region.
Primary research
Analysts interviewed RPM program directors and nurse managers at U.S. health systems, revenue-cycle leaders who bill monitoring codes, product managers at connected-device and platform vendors, and care-management buyers at payers. Interviews tested assumptions on enrollment duration, monthly revenue per patient, device replacement cycles and the share of programs run by outsourced service teams.
Secondary research
Secondary sources include HHS-OIG evaluations of Medicare RPM (2024 and 2025), CMS Physician Fee Schedule final rules, FDA 510(k), De Novo and PMA databases, company annual reports and investor presentations, NHS England virtual ward statistics, German EBM telemonitoring rules, WHO and IDF disease prevalence reports, and peer-reviewed studies such as the Providence remote care program published in NEJM Catalyst in 2025.
Data validation
Segment and regional values were reconciled to the USD 12,486.2 Mn base-year total, country values were checked against their regional totals, and growth rates were compared with reported revenue trends at listed device makers and with Medicare payment growth. Enrollment and revenue-per-patient assumptions were triangulated against program volumes disclosed by health systems and vendors.
Market Coverage Definitions
How this report defines the scope of the Remote Patient Monitoring Services Market: what each segment and sub-segment includes.
| Segment | Market Coverage Definition |
|---|---|
| By Component | Segments the market by what is purchased, covering devices, software and analytics, and services. |
| By Application | Segments the market by the clinical condition monitored, covering cardiovascular disease monitoring, diabetes management, respiratory disease monitoring, and weight management and other applications. |
| By End User | Segments the market by who manages the monitoring program, covering hospitals and providers, homecare settings, and payers. |
| By Connectivity | Segments the market by how devices transmit patient data, covering cellular-enabled, Bluetooth and Wi-Fi-enabled, and other connectivity types. |
By Component
| Sub-Segment | Market Coverage Definition |
|---|---|
| Devices | Connected monitoring hardware, including blood pressure cuffs, weight scales, pulse oximeters, and glucose meters, the largest component category given that a device is required to initiate every monitoring program. |
| Software & Analytics | Platforms that collect, analyze, and present patient-generated data to care teams, including alerting, trending, and electronic health record integration capabilities. |
| Services | Clinical monitoring, patient onboarding, technical support, and billing services that service providers deliver alongside devices and software, often on a per-patient subscription basis. |
By Application
| Sub-Segment | Market Coverage Definition |
|---|---|
| Cardiovascular Disease Monitoring | Remote monitoring of blood pressure, heart rate, and heart failure indicators, the largest application given the prevalence of hypertension and heart failure management programs. |
| Diabetes Management | Remote monitoring of blood glucose levels and related metrics to support diabetes care and reduce complications. |
| Respiratory Disease Monitoring | Remote monitoring of oxygen saturation and respiratory function for conditions such as chronic obstructive pulmonary disease and asthma. |
| Weight Management & Others | Remote monitoring of body weight and additional chronic conditions not captured in the categories above. |
By End User
| Sub-Segment | Market Coverage Definition |
|---|---|
| Hospitals & Providers | Health systems and physician practices that operate remote patient monitoring programs directly, the largest end-user group given the central role hospitals play in chronic disease management. |
| Homecare Settings | Home health agencies and direct-to-patient monitoring arrangements that extend care beyond the clinical setting. |
| Payers | Health insurers and managed care organizations that sponsor or reimburse remote monitoring programs as part of chronic disease management and cost containment efforts. |
By Connectivity
| Sub-Segment | Market Coverage Definition |
|---|---|
| Cellular-Enabled | Devices that transmit data over cellular networks without requiring a separate internet connection or smartphone pairing, reducing setup complexity for patients. |
| Bluetooth/Wi-Fi-Enabled | Devices that transmit data through a paired smartphone application or home Wi-Fi network, typically at a lower device cost than cellular-enabled alternatives. |
| Others | Additional connectivity approaches, including devices that require manual data entry or periodic data upload. |
Market Assessment Framework
The four-step framework used to size and validate the Remote Patient Monitoring Services market.
- 1
Bottom-Up Approach
Market size is built from the number of enrolled patients across hospitals and providers, homecare settings, and payer-sponsored programs, combined with average per-patient monthly spend on devices, software and analytics, and monitoring services, then aggregated across clinical applications and regions to arrive at total market value.
- 2
Volume-Based Assessment
Patient enrollment volume is estimated from disclosed program sizes at major remote patient monitoring service providers and health systems, cross-checked against published Medicare and commercial payer billing data for remote monitoring service codes.
- 3
Price & Revenue Benchmarking
Average selling prices and service fees are benchmarked across device types, software subscription models, and monitoring service packages, using published reimbursement rates, vendor pricing, and disclosed acquisition values, then triangulated against reported segment revenue from major remote patient monitoring companies.
- 4
Market Validation & Triangulation
Preliminary estimates are validated through structured interviews with health system program directors, payer medical management leads, and remote patient monitoring company executives, and cross-checked against company financial disclosures, regulatory filings, and secondary research to reconcile top-down and bottom-up estimates within an acceptable variance.
Specialized Analyst Insights
CoachCare's acquisition of VitalTech, its eighth acquisition since 2023, and Health Recovery Solutions' acquisition of Rimidi, its sector's fourth disclosed remote patient monitoring deal of 2026, both point to the same underlying pattern: service providers are building scale and clinical breadth by acquiring complementary platforms rather than building every capability internally. Combining a general remote monitoring platform with a condition-specific tool, such as Rimidi's diabetes and cardiometabolic focus, lets an acquirer offer a broader program to health system customers without a multi-year internal build.
ChartSpan's acquisition of Validic, reported as the eighth remote patient monitoring deal and 111th overall eHealth acquisition tracked in 2026 by the cited source, suggests the pace of consolidation in remote patient monitoring services accelerated through the first half of 2026 compared with the prior year. As more service providers combine clinical services with device and data infrastructure under one roof, independent point-solution vendors may find it harder to compete without a service layer or distribution partnership of their own.
Abbott's FDA clearance for the next-generation CardioMEMS HERO reader, which adds built-in Wi-Fi and cellular connectivity and is substantially lighter than earlier models, shows that device-level innovation continues alongside the service-layer consolidation happening elsewhere in the market. The company cited a 57% reduction in hospitalizations associated with the earlier CardioMEMS system, underscoring why device makers keep investing in incremental improvements to already-validated monitoring technology rather than only pursuing new indications.
MiCare Path's combination of a funding round with a tuck-in acquisition of Compwell in the same announcement illustrates a financing pattern increasingly common among smaller remote patient monitoring companies: pairing new capital directly with an acquisition that adds service depth, rather than raising funds first and acquiring later. This approach lets a company expand its service offering and demonstrate growth to investors in a single step, though it also means the acquired company's integration risk arrives at the same time as the capital intended to support it.
Regional Regulations
Regulatory authorities and requirements across 9 jurisdictions
| Region | Key Regulatory Authorities / Frameworks | Government Regulations and Regulatory Considerations |
|---|---|---|
| North AmericaU.S. | U.S. FDA, CMS | Remote patient monitoring devices used for physiologic data collection require FDA clearance, while reimbursement for monitoring services is governed separately by CMS under dedicated remote patient monitoring billing codes within the Medicare Physician Fee Schedule, which CMS periodically revises. |
| Europe | European Medicines Agency, Notified Bodies | Remote patient monitoring devices marketed in Europe require Medical Device Regulation certification, while reimbursement for monitoring services varies by member state national health system policy rather than a single EU-wide framework. |
| Asia PacificJapan | MHLW, PMDA | Remote patient monitoring devices in Japan are regulated under the Pharmaceuticals and Medical Devices Act, with reimbursement for monitoring services evaluated through the national health insurance system. |
| Asia PacificChina | NMPA | China's NMPA regulates remote patient monitoring devices as medical devices, with growing domestic adoption supported by national chronic disease management initiatives. |
| Asia PacificIndia | CDSCO | Remote patient monitoring devices in India fall under the Medical Device Rules administered by the CDSCO, with adoption growing alongside expanding telehealth and chronic disease management infrastructure. |
| Asia PacificSouth Korea | MFDS | South Korea's Ministry of Food and Drug Safety regulates remote patient monitoring devices, with national health insurance policy shaping reimbursement for monitoring services. |
| Latin AmericaBrazil | ANVISA | Remote patient monitoring devices in Brazil are regulated as medical devices by ANVISA, with adoption concentrated among private health insurers and larger hospital systems. |
| Middle East | National health product regulatory authorities, GCC frameworks | Remote patient monitoring regulation continues to develop across the region alongside growing investment in chronic disease management and digital health infrastructure. |
| Global / International | ISO, IEC | ISO and IEC standards for medical device software and data security shape manufacturing and data handling expectations for remote patient monitoring devices and platforms marketed internationally. |
Strategic Activities
5 strategic developments shaping the Remote Patient Monitoring Services Market
| Date | Company / Companies | Development Type | Development and Impact on Market |
|---|---|---|---|
| Mar 2025 | CoachCare, VitalTech | Acquisition | CoachCare, a New York-based remote patient monitoring and care management provider, acquired VitalTech, an enterprise virtual care software company, in its eighth acquisition since 2023. The deal adds VitalTech's remote monitoring and care coordination platform, used by health systems, managed care organizations, and senior living facilities, to CoachCare's existing chronic care management services. [source] |
| Nov 2025 | MiCare Path, Compwell | Funding / Acquisition | MiCare Path closed its fourth funding round, with the amount undisclosed, and simultaneously acquired Compwell LLC, a Tennessee-based provider of care management and virtual assessment services, in a tuck-in deal. The company said the combined moves would support national expansion and further investment in AI-driven virtual care capabilities. [source] |
| Feb 2026 | Abbott | Regulatory Clearance | Abbott received FDA clearance for its next-generation CardioMEMS HERO reader, which the company said is about 60% lighter than earlier models and adds built-in Wi-Fi and cellular connectivity so heart failure patients can transmit pulmonary artery pressure readings remotely. Abbott cited a 57% reduction in hospitalizations associated with the earlier CardioMEMS system. [source] |
| Mar 2026 | Health Recovery Solutions, Rimidi | Acquisition | Health Recovery Solutions acquired Rimidi, an Atlanta-based chronic disease management and remote monitoring company focused on diabetes and cardiometabolic care, in what was reported as the fourth disclosed remote patient monitoring deal of 2026. The acquisition lets HRS customers access Rimidi's diabetes management tools alongside its existing PatientConnect platform. [source] |
| Jun 2026 | ChartSpan, Validic | Acquisition | ChartSpan, a preventive care management company, acquired Validic, a healthcare technology company that integrates connected health devices and data for health systems and payers, in what was reported as the eighth remote patient monitoring deal and 111th overall eHealth acquisition tracked so far in 2026. The combined company will offer clinical services, devices, and data infrastructure together under the ChartSpan name. [source] |
Related Analysis
Blog · Healthcare ServicesRemote Patient Monitoring Services Are Consolidating Faster Than the Devices Are Changing
Three acquisitions in sixteen months show service providers racing to combine platforms and clinical services under one roof, even as Abbott proves there is still room for genuine device-level innovation.
Read the article →Table of Contents: Remote Patient Monitoring Services Market Report
14 chapters · 98 tables & 72 figures. Expand a chapter to see its sub-sections.
Introduction and Research Scope
- Market Definition and Report Scope
- Research Methodology
- Assumptions and Currency Conventions
Executive Summary
- Global Market Snapshot, 2025 and 2035
- Key Findings by Segment and Region
Market Dynamics
- Growth Drivers
- Restraints
- Opportunities
- Challenges
- Role of AI in Remote Patient Monitoring
Remote Patient Monitoring Services Market Analysis, By Component
- Devices
- Software & Analytics
- Services
Remote Patient Monitoring Services Market Analysis, By Application
- Cardiovascular Disease Monitoring
- Diabetes Management
- Respiratory Disease Monitoring
- Weight Management and sleep disorder monitoring
Remote Patient Monitoring Services Market Analysis, By End User
- Hospitals & Providers
- Homecare Settings
- Payers
Remote Patient Monitoring Services Market Analysis, By Connectivity
- Cellular-Enabled
- Bluetooth/Wi-Fi-Enabled
- Satellite and Zigbee connectivity
Remote Patient Monitoring Services Market Production & Volume Analysis
- Active Patient Enrollments, 2025
- Volume Split by Component
- Implied Annual Revenue per Enrolled Patient
Remote Patient Monitoring Services Market Analysis, By Region
- North America
- Europe
- Asia Pacific
- Latin America
- The Middle East
- Africa
Competitive Landscape
- Market Structure and Concentration
- Company Positioning Matrix
- Mergers, Acquisitions and Partnerships, 2025–2026
Company Profiles
- Koninklijke Philips
- Medtronic
- Abbott Laboratories
- Omron Healthcare
- Dexcom
- iRhythm Technologies
- Masimo
- Vivalink
- Smart Meter
- Teladoc Health
- Biofourmis
- Cadence
- Health Recovery Solutions
- CoachCare
- ChartSpan
Value Chain and Supply Chain Analysis
- Device Manufacturing and Connectivity
- Platform and Data Integration
- Clinical Service Delivery and Billing
Regulatory and Reimbursement Environment
- United States: CMS and FDA
- Europe: MDR and National Telemonitoring Programs
- Asia Pacific: Japan, South Korea and China
Appendix
List of Tables (selected)
- Global Remote Patient Monitoring Services Market Size, 2023–2035 (USD Million)
- Remote Patient Monitoring Services Market Size, By Component, 2023–2025 (USD Million)
- Remote Patient Monitoring Services Market Size, By Component, 2026–2035 (USD Million)
- Remote Patient Monitoring Services Market Size, By Application, 2023–2025 (USD Million)
- Remote Patient Monitoring Services Market Size, By Application, 2026–2035 (USD Million)
- Remote Patient Monitoring Services Market Size, By End User, 2023–2025 (USD Million)
- Remote Patient Monitoring Services Market Size, By Connectivity, 2023–2025 (USD Million)
- Remote Patient Monitoring Services Market Production & Volume, By Component, 2025 (active patient enrollments)
- Remote Patient Monitoring Services Market Size, By Region, 2025 (USD Million)
- North America Remote Patient Monitoring Services Market Size, By Country, 2023–2035 (USD Million)
- U.S. Remote Patient Monitoring Services Market Size, By Component, 2023–2035 (USD Million)
- Europe Remote Patient Monitoring Services Market Size, By Country, 2023–2035 (USD Million)
- Germany Remote Patient Monitoring Services Market Size, By Application, 2023–2035 (USD Million)
- Asia Pacific Remote Patient Monitoring Services Market Size, By Country, 2023–2035 (USD Million)
- South Korea Remote Patient Monitoring Services Market Size, By End User, 2023–2035 (USD Million)
- Latin America Remote Patient Monitoring Services Market Size, By Country, 2023–2035 (USD Million)
- The Middle East Remote Patient Monitoring Services Market Size, By Country, 2023–2035 (USD Million)
- Africa Remote Patient Monitoring Services Market Size, By Country, 2023–2035 (USD Million)
- Key Companies: HQ, Primary Focus and Recent Actions
- Recent Developments, 2025–2026
List of Figures (selected)
- Global Remote Patient Monitoring Services Market Size, 2025–2035 (USD Million)
- Remote Patient Monitoring Services Market Share by Region, 2025
- Remote Patient Monitoring Services Market Share, By Component, 2025 (%)
- Remote Patient Monitoring Services Market Share, By End User, 2025 (%)
- Remote Patient Monitoring Services Market: Drivers, Restraints, Opportunities & Challenges
- Remote Patient Monitoring Services Market — Segmentation Overview
- Remote Patient Monitoring Services Market — Component Mix by Region
- Remote Patient Monitoring Services Market — Competitive Landscape
- Remote Patient Monitoring Services Market — At a Glance
- United States Remote Patient Monitoring Services Market Size, 2023–2035
- Germany Remote Patient Monitoring Services Market Size, 2023–2035
- South Korea Remote Patient Monitoring Services Market Size, 2023–2035
You May Also Be Interested In
Telehealth Market
Overlapping buyer persona: health-system virtual care leaders buy both.
Continuous Glucose Monitoring Devices Market
Supply chain: CGMs are a core device input to diabetes RPM programs.
Hospital-at-Home Market
Same end-use setting: acute care at home depends on continuous remote monitoring.
Wearable Medical Devices Market
Supply chain: wearable biosensors feed monitoring platforms.
Chronic Care Management Market
Overlapping services: CCM and RPM are billed and delivered together.
All VMI market research reports available in PDF. Contact sales@vectomatinsights.com
Frequently Asked Questions
What is the market size of remote patient monitoring services in 2025?
Vectomat Insights values the global remote patient monitoring services market at USD 12,486.2 Mn in 2025. Devices account for USD 5,493.9 Mn, software and analytics for USD 3,745.9 Mn and services for USD 3,246.4 Mn. The market is forecast to reach USD 49,945.5 Mn by 2035 at a 14.87% CAGR across the 2026–2035 forecast period, according to Vectomat Insights.
Which application segment holds the largest share?
Cardiovascular disease monitoring holds the largest application share at 31.7% of 2025 revenue, or USD 3,956.0 Mn, because hypertension and heart failure dominate Medicare RPM enrollment. Diabetes management is the fastest-growing application at 20.04% a year and becomes the largest by 2035 at USD 20,412.9 Mn as CGMs reach non-insulin type 2 patients, according to Vectomat Insights.
Who are the main end users of remote patient monitoring services?
Hospitals and providers are the main end users with 45.8% of 2025 revenue, or USD 5,716.2 Mn, and they are also the fastest-growing at 19.6% a year. Homecare settings hold 36.0% and payers 18.2%. Payers mostly buy through care-management vendors. Providers dominate because the ordering clinician also bills the treatment-management codes that fund each program, according to Vectomat Insights.
How did the 2026 Medicare changes affect remote patient monitoring billing?
For 2026, CMS finalized Physician Fee Schedule codes that pay for 2–15 days of monitoring data in a 30-day period, replacing the earlier 16-day minimum, and added a shorter management tier for 10 minutes of clinical time. Billing staff should update enrollment rules accordingly. The change makes intermittent and post-discharge patients billable and widens the enrollment base for providers, according to Vectomat Insights.
How large is the U.S. remote patient monitoring services market?
The U.S. remote patient monitoring services market was worth USD 4,988.2 Mn in 2025, up from USD 3,858.5 Mn in 2023, and is projected to reach USD 18,011.4 Mn by 2035 at a 13.7% CAGR. Nearly 1 million Medicare enrollees received RPM in 2024, and Medicare payments rose 31% that year to USD 536 Mn, according to Vectomat Insights.
Which connectivity type is growing fastest in RPM devices?
Satellite and Zigbee connectivity is the fastest-growing connectivity segment at 22.83% a year, rising to USD 15,610.7 Mn by 2035 as non-terrestrial network modules reach wearables and home hubs. Bluetooth and Wi-Fi devices hold 34.0%. Cellular-enabled devices still lead with 50.0% of 2025 revenue because they work without a smartphone or home Wi-Fi, which suits older patients, according to Vectomat Insights.
What research methodology does this report use?
The report combines a bottom-up model built from enrolled patients and annual revenue per enrollment with a top-down check against company revenue, Medicare RPM payment data and national telemonitoring volumes. Primary interviews with RPM program directors, revenue-cycle leaders, vendors and payers tested key assumptions, and all segment, regional and country values were reconciled to the base-year total, according to Vectomat Insights.
Access the Complete Remote Patient Monitoring Services Market Report
300+ pages | 98 tables & 72 figures | 2026–2035 | All 6 regions | PDF
Contact: sales@vectomatinsights.com
About Vectomat Insights
Vectomat Insights is an independent market research firm. Our analysts build every market model in-house, from company revenues, government and regulatory data, and interviews with industry participants, and each report is reviewed by a senior analyst and fact-checked before publication.
Contact: Vectomat Insights | Email: sales@vectomatinsights.com | Website: www.vectomatinsights.com
Request a free sample
Ready to go deeper? Request a free sample of the VMI Remote Patient Monitoring Services Report — preview key data tables, segmentation depth, and regional forecasts before purchasing.
About this report
Get a free sample of this report
Remote Patient Monitoring Services Market